APIs for research and impurities

<p>N-desmethyl sorafenib is an analytical standard for the HPLC assay of sorafenib. It is a metabolite of sorafenib, which is a drug used in the treatment of cancer. It has been shown to inhibit protein synthesis and cell growth in vitro and in vivo. N-desmethyl sorafenib has been shown to inhibit the activity of methionine adenosyltransferase, leading to inhibition of DNA synthesis. The chemical properties are similar to those of other drugs that have been approved by the US Food and Drug Administration.</p>

<p>Pravastatin 6-oxo Impurity is an impurity of Pravastatin, a drug used in the treatment of high cholesterol. The impurity has been identified through analytical methods and is characterized by HPLC analysis. This substance has been shown to be present in at least 0.1% of the drug product and may be present as a result of incomplete synthesis or a side-reaction during synthesis.</p>

<p>Ampicillin desoxocarboxylic acid-[(R)-(phenyl-d5)glycine] is an analytical standard for HPLC. It has the CAS number 1207726-28-0 and is available in various quantities. The impurity of this standard is determined by the HPLC chromatogram and can be found in the USP and EP. This product is a drug product that has niche application, meaning it's not a common pharmaceutical ingredient. It can be used as a metabolite or impurity standard for pharmacopoeia purposes. Custom synthesis and natural are also possible options for purchase.</p>

<p>Please enquire for more information about Carbofuran N,N-dibutyl-3λ1-trisulfan-1-amine including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>6-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, racemic is a drug product that is used as an analytical standard in the development of new drugs. It is also used to study the metabolism of drugs. 6BPDC has been shown to inhibit bacterial growth by binding to DNA and RNA, thereby preventing transcription and replication. This metabolite can be synthesized in the laboratory.</p>

<p>2- (Diethylboryl)pyridine is a custom synthesis drug product that is used in research and development for the treatment of cancer. 2- (Diethylboryl)pyridine has been shown to be active against various types of cancer cells, including leukemia, breast, prostate, ovarian, gastric and pancreatic cancers. This compound can also be used as an impurity standard for HPLC analysis.</p>

<p>Please enquire for more information about 1-(4-Methyl-2,5-dioxoimidazolidin-4-yl)urea including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Pyrimido[1,2-a]purin-10(1H)-one is a cytotoxic drug used in the treatment of various cancers. It is an analog of purine nucleoside and has been shown to inhibit mitochondrial functions and nuclear DNA synthesis, as well as to induce malondialdehyde production. Pyrimido[1,2-a]purin-10(1H)-one also inhibits protein synthesis by methyltransferase inhibition. The detection sensitivity of pyrimido[1,2-a]purin-10(1H)-one has been demonstrated using titration calorimetry on sephadex g-100 columns. This compound is not active against E. coli K12 but is active against other bacteria including Staphylococcus aureus isolates that are resistant to methicillin.</p>

<p>Please enquire for more information about N-Acetyl o-benzyl 5’-epi lamivudine including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

ITE analog is an anticancer agent that works by inhibiting the activity of certain kinases in cancer cells. This inhibitor has been shown to induce apoptosis and inhibit tumor growth in both human and Chinese hamster ovary cell lines. ITE analog is a protein toxin that can be found in urine, but the synthetic analog is more potent and selective than the natural compound. This analog has been tested against a variety of kinases, including those involved in cancer cell proliferation, and has shown promising results as a potential treatment for cancer. Its unique mechanism of action makes it a valuable addition to the arsenal of anticancer drugs available today.

Gastrofensin an 5 is a drug product that is undergoing research and development. It is not yet approved for use in humans. Gastrofensin an 5 is used as a reference substance in analytical work, metabolism studies, and natural product analysis. The CAS No. for this compound is 89845-16-9. Gastrofensin an 5 has the following impurities: 0.1% (m/m) of 2-(6-chloroquinolin-2-yl)acetic acid; 0.1% (m/m) of 2-(6-chloroquinolin-3-yl)acetic acid; 0.1% (m/m) of 2-(6,7-dichloroquinolyl)-acetic acid; 0.1% (m/m) of 3-(6,7 dichloroquinolyl)-acetic acid; 0.1% (

<p>Ai Product Descriptions 50 Creative</p>

Please enquire for more information about 7-Hydroxy-furo[3,4-b]pyrazin-5-one including the price, delivery time and more detailed product information at the technical inquiry form on this page

Mdl 72832 hydrochloride is a ligand that modulates the activity of nerve cells. It has been shown to activate and synergistically enhance the effects of nerve growth factor (NGF) and acetylcholine on neurons. Mdl 72832 hydrochloride also increases the synthesis and release of melanocortins, which are neurotransmitters that are involved in regulating appetite, mood, and pain sensation. Mdl 72832 hydrochloride may be a potential nootropic agent for the treatment of neurodegenerative diseases such as Alzheimer's disease or Parkinson's disease.

<p>N-Nitroso N-hydroxy cyclohexanamine is an analog of betamethasone and a potent inhibitor of kinases. It has been shown to have anticancer properties by inducing apoptosis in cancer cells. This compound is excreted in urine and has been studied extensively in Chinese populations for its potential as an anticancer agent. N-Nitroso N-hydroxy cyclohexanamine inhibits the activity of kinases, which are important enzymes involved in cell signaling pathways that regulate cell growth and division. This inhibition leads to the suppression of tumor growth and the induction of apoptosis in cancer cells. Additionally, this compound has been found to be a potent inhibitor of vitamin D receptor (VDR) and may play a role in regulating VDR-mediated gene expression.</p>

N-Desmethyl N-hydroxymethyl regorafenib is a drug product that is used in the development of new drugs. It is a chemical intermediate that has been synthesized to produce a desired metabolite. The molecule contains two methyl groups, two hydroxyl groups, and one carboxylic acid group on the aromatic ring. This product has been purified to high purity by analytical methods.

N-Desmethyl sorafenib (pyridine)-N-oxide is a drug product that can be used as an HPLC standard and is also used in the development of drugs. CAS No. 583840-04-4 is a metabolite impurity that can be found in the analytical API impurity of the drug. This synthetic compound is subject to metabolism studies, which are conducted on animals for pharmacopoeia purposes. N-Desmethyl sorafenib (pyridine)-N-oxide has shown niche applications in the field of research and development, as it can be used as an analytical standard for HPLC.

Motexafin lutetium hydrate is a radioactive drug that is used in the diagnosis of skin cancer. The drug binds to the chemoattractant protein CXCL1 and pro-apoptotic protein BID, leading to the accumulation of these proteins at the mitochondria membrane potential. This accumulation induces apoptosis by inhibiting mitochondrial activity. Motexafin lutetium hydrate has also been shown to be effective against a number of bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus faecalis, and Escherichia coli. It has also been shown to have anti-inflammatory effects in animal models, which may be due to its inhibition of prostaglandin synthesis.

(R)-2-Amino-2-methyl-N-[4-phenyl-1-[[4-[2-[2-(1H-tetrazol-5-yl)ethyl]phenyl]-1-piperidinyl]carbonyl]butyl]propanamide is a synthetic drug that has been used in research and development. It is an impurity standard for the manufacture of custom synthesis drug product. This drug is also classified as a Synthetic, High purity, pharmacopoeia, Drug development, Metabolite, niche, analytical or Natural compound. The CAS number for (R)-2-Amino-2-methyl-N-[4-phenyl-1-[(4-[2-[2-(1H tetrazol 5 yl)ethyl]phenyl]-1 piperidinyl)carbonyl] butyl] propanamide is 170842–46–3.

<p>Please enquire for more information about 2-Amino-5-(2-bromoacetyl)benzonitrile hydrobromide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>